Chemical Structure : LUNA18
Catalog No.: PC-22631Not For Human Use, Lab Use Only.
LUNA18 (LUNA-18) is a highly potent, 11-mer cyclic peptide inhibitor for the intracellular tough target RAS with IC50 of <2 nM for KRAS G12D-SOS1 PPI, KD of 0.043 nM for KRAS G12C.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LUNA18 (LUNA-18) is a highly potent, 11-mer cyclic peptide inhibitor of KRAS with IC50 of <2 nM for KRAS G12D-SOS1 PPI, KD of 0.043 nM for KRAS G12C.
LUNA18 has a cellular IC50 of 1.4 nM in AsPC-1 viability assay.
LUNA18 showed significant cellular efficacy (IC50 = 0.17-2.9 nM) against cell lines with KRAS genetic alterations, such as LS180 (colon cancer, KRASG12D), GSU (stomach cancer, KRASG12D), NCI-H441 (non-small cell lung cancer (NSCLC), KRASG12V), NCI-H2122 (NSCLC, KRASG12C), and MiaPaCa-2 (pancreatic cancer, KRASG12C), in addition to AsPC-1.
LUNA18 (10 mg/kg, oral, once daily for 14 days) exhibits in vivo tumor growth inhibition in in mice bearing an NCI-H441 (KRAS G12V) or a MiaPaCa-2 (KRASG12C) xenograft.
M.Wt | 1437.71 | |
Formula | C73H105F5N12O12 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Tanada M, et al. J Am Chem Soc. 2023 Aug 2;145(30):16610-16620.
2. Nomura K, et al. J Med Chem. 2022 Oct 13;65(19):13401-13412.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright